Aggredyne closes $3 million Series A convertible preferred stock financing Aggredyne.

Aggredyne can be preparing to file with the Food and Drug Administration a 510 for clearance to market its initial item, the AggreGuideTM A-100, and related blood platelet assessment. The AggreGuide is normally a patented, simple, inexpensive, laser-light-scattering platelet aggregometer that quickly analyzes a patient’s responsiveness to his anti-platelet medicine. Related StoriesNew medical chemistry analyzer launched by EKF at Medica 2015Transitioning infrared imaging into clinical make use of: an interview with Dr Matthew BakerNew generation of RNAscope items for RNA-biomarker evaluation in FFPE cells releasedThe technology was developed by researchers affiliated with the Utah Artificial Center Institute and originally licensed from Brigham Young University to Thrombodyne, Inc.Thus, it continues to be in the expanded condition. As the central starting gets widened, eye professionals in Bangalore may clearly look the inner parts. * The examination: Special magnifying lens can be used for looking at the retina, the macula, tissues and blood vessels. They also appear t the optic nerve and check when there is any abnormality. Swelling, inflammation, abnormal growth or modification in the colour or texture of the internal parts indicates vision complications. Doctors do various other investigations if required and prescribe the procedure. * Follow-up: Doctors call for a follow-up evaluation after prescribing treatment.